Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
about
Cardiovascular outcomes in trials of oral diabetes medications: a systematic reviewRosiglitazone for type 2 diabetes mellitusModulation of diabetic retinopathy pathophysiology by natural medicines through PPAR-γ-related pharmacology.Thiazolidinediones and risk of heart failure in patients with or at high risk of type 2 diabetes mellitus: a meta-analysis and meta-regression analysis of placebo-controlled randomized clinical trials.A comparison of glycaemic and metabolic control over time among South Asian and European patients with Type 2 diabetes: results from follow-up in a routine diabetes clinic.Addition of thiazolidinedione or exenatide to oral agents in type 2 diabetes: a meta-analysis.
P2860
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@en
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@nl
type
label
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@en
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@nl
prefLabel
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@en
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@nl
P2093
P2860
P1433
P1476
Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.
@en
P2093
A H Barnett
G A Hitman
Indo-Asian Trial Investigators
L Robertson
P2860
P304
P356
10.1046/J.1464-5491.2003.00925.X
P577
2003-05-01T00:00:00Z